Patients and settings

Patients included in the study were users of the MDD system [23], aged 75 years and older, living in nursing homes or in their own homes with municipally provided home care.

Patient data were collected from a separate randomised controlled trial (RCT) examining whether multi-professional drug reviews including a pharmacist could improve the quality of pharmacotherapy among elderly primary health care patients [24]. At baseline, nurses completed a symptom checklist using the Pharmacotherapeutical Symptom Evaluation 20 (PHASE-20) tool [25] and sent the results to a pharmacist participating in the study. PHASE-20 includes 20 questions and is designed to identify drug-related symptoms (Additional file 1) [25]. For this study, all intervention and control patients from the aforementioned study [24] were included. Information on baseline characteristics, such as age, sex, residency, locomotion and blood pressure, was extracted from the PHASE-20 responses.

The study received ethical approval from the Regional Ethical Review Board in Lund (no. 2011/245).

Data collection

The patients were recruited to the RCT between September 1 and December 16 2011.

Data collection for the present study was conducted between September 1 2012 and February 15 2013. Baseline drug lists were screened for FRIDs and ODs according to the NBHW list. To facilitate the identification of FRIDs and ODs, a list of all generic names and product names was created. All identified drugs were classified according to the Anatomical Therapeutic Chemical (ATC) classification system [26]. Every drug was counted as one with its unique ATC code regardless of the dosage or number of pills for the individual patient. Data on FRIDs and ODs were collected and analysed separately due to the distinction made by the NBHW and the fact that drugs from certain ATC groups (e.g. antipsychotics) appear on both the FRID and OD lists.

The data for reported falls and severe falls were collected. Reported falls were defined as falls during the past three months reported by the nurse in the patient’s PHASE-20 checklist evaluation. Severe falls were defined as falls leading to emergency visits at hospitals or hospital admission as a consequence of syncope, contusion or bone fracture during the previous year as documented in the patient’s EMR. Data on hospital admissions and hospital emergency visits relating to falls during the year prior to inclusion in the study were collected from the patient’s hospital electronic medical records (EMRs).

Data analysis

Primary outcome measures were incidence of falls as well as numbers of FRIDs and ODs in fallers and non-fallers. The secondary outcome measure was distribution of drug types among FRIDs and ODs. Data were analysed using Student’s t-test and Fischer’s exact test for two-group comparisons, and multiple linear regression (backward method) analyses. In the two regression analyses FRIDs and ODs were used as the respective dependent variables while age, gender, place of living, number of drugs and severe falls were entered as independent variables. A significance level of a = 0.05 was chosen. All data were analysed using IBM SPSS version 20.0.

Main findings

Patients who had fallen were prescribed a higher number of continuous-use FRIDs than patients with no reported falls. A significant proportion (87%) of the study sample was taking FRIDs and ODs, as in other studies [27]. More men reported falls during the past three months; however, more women suffered from severe falls leading to emergency visits or hospital admission during the past year.

The study sample had a high incidence of both reported falls during the last three months (29%) and severe falls (17%). The results are similar to previously published results [28]. Data for reported falls during the past three months might have included severe falls and this explains the higher incidence of reported falls.

Fallers used a higher number of FRIDs, consistent with the findings of similar studies [29]. It is difficult to compare FRID data between different studies, since there are several different FRID classifications. Other international FRID lists include analgesics, hypoglycaemics and urinary antispasmodics [30–32]. Since drugs from these classes were not included in the Swedish NBHW lists, our results may differ from studies using more extensive FRID and OD lists. We chose not to merge the FRID and the OD lists from the NBHW but to present the results separately, because some drugs (e.g. antipsychotics) are classified both as FRIDs and as ODs.

Female sex and residency in nursing homes were associated with severe falls. Due to low bone mass, the presence of osteoporosis and low muscle strength, females are more likely than males to experience a fall-related injury [33, 34]. In our study, female sex was associated with a higher number of FRIDs and this might explain the association with severe falls. Nursing home patients have increased care needs due to cognitive impairment, multiple illnesses and the use of a high number of drugs, and might therefore be more prone to fall. Numbers of FRIDs and ODs were associated with the total number of drugs and with severe falls. This is in agreement with previous studies showing strong evidence of an association between the use of psychoactive drugs and falls in the elderly [18], as well as between polypharmacy and falls [10, 35, 36].

A majority of the patients were females, lived in nursing homes and had a high number of drugs, as in other studies [37].

Antidepressants and anxiolytics were the most frequently used FRIDs and have been previously found to predispose elderly patients to falling [38]. The most frequently prescribed FRID in the study sample was oxazepam. Due to their muscle-relaxing effects, benzodiazepines have been associated with an increased risk of hip fractures in the elderly [39]. Cardiovascular drugs such as the commonly prescribed diuretic furosemide can cause or worsen orthostatic hypotension. However, there was no association between the numbers of ODs and falls in this study.

Almost a third of the patients complaining of moderate to severe symptoms of dizziness or unsteadiness reported falling in the three months prior to the study, compared to less than 10% of those who had no complaints. This suggests that the PHASE-20 symptom checklist might be a useful tool to predict falls among elderly patients. One strength of this study is that the drug lists are accurate and compliance with prescribed drug therapy was high due to the use of the MDD system. The reliability of the data is high since it was collected in a standardized manner by a single individual. The studied sample was from several different geographic regions in Skåne, Sweden, which increases the generalizability of our results. PHASE-20 was found to have acceptable consistency, test-retest reliability and internal validity [25]. Nurses that used the symptom checklist (PHASE-20) had direct contact with the patients, which ensured more accurate description of their symptoms.

Limitations

A major limitation of the study is the cross-sectional design with collection of retrospective data about falls. Since no risk assessment tool was used, we are unable to stratify patients into low and high risk for falls. Data on patients’ diagnoses were not collected. It is therefore hard to draw a firm conclusion as to whether the cognitive impairment itself or the treatment of its symptoms is associated with falls.

Another major limitation of the study is also the lack of geriatric assessment. The identification of cognitive impairment, comorbidity and functional disability would clarify the contribution of other potential factors in increased fall risk.

Another limitation is that we assessed data about number of FRIDs and ODs regardless of the defined daily dosage of each drug. More detailed drug information might have provided better understanding of whether drug dosage affects fall risk.

All patients were included in the fall evaluation, even though some of them were not ambulatory. This may have caused some bias, since the chair-bound and bed-bound patients were not able to walk freely and were possibly less prone to falling.

Since the study is retrospective, it is not known what each study patient’s drug profile was during the period prior to the PHASE-20 evaluation.

Future research

Interventions to optimize drug therapy in elderly patients with an emphasis on preventing falls would need to use a fall risk assessment tool including FRIDs to be able to stratify the patients into low and high risk of falling. A prospective study design would also confirm the strength of the association between exposure to FRIDs and subsequent falls.

All our patients used the MDD system. Although this system was originally developed to improve patient safety and drug compliance among those with multiple chronic co-morbidities, studies indicate that the use of the MDD system may be associated with a higher number of drugs, especially psychotropics [40], and poorer drug treatment. Future research should assess the possible effect of medication reviews with an emphasis on FRIDs and falls as a method to increase the quality of drug treatment in the elderly.